CIENCIASMEDICASNEWS: Findings suggest a need to closely monitor CVD risk factors in men with type 2 diabetes treated with GnRH agonists

lunes, 29 de agosto de 2022

Findings suggest a need to closely monitor CVD risk factors in men with type 2 diabetes treated with GnRH agonists

Findings suggest a need to closely monitor CVD risk factors in men with type 2 diabetes treated with GnRH agonists

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)